Not all epidermal growth factor receptor mutations in lung cancer are created equal: Perspectives for individualized treatment strategy von Kobayashi, Yoshihisa, Mitsudomi, Tetsuya

Volltext

Mutations of the epidermal growth factor receptor gene and related genes as determinants of epidermal growth factor receptor tyrosine kinase inhibitors sensitivity in lung cancer von Mitsudomi, Tetsuya, Yatabe, Yasushi

Volltext

Epidermal growth factor receptor in relation to tumor development: EGFR gene and cancer von Mitsudomi, Tetsuya, Yatabe, Yasushi

Volltext

Utility of the Ba/F3 cell system for exploring on‐target mechanisms of resistance to targeted therapies for lung cancer von Koga, Takamasa, Suda, Kenichi, Mitsudomi, Tetsuya

Volltext

Osimertinib for pretreated EGFR Thr790Met-positive advanced non-small-cell lung cancer (AURA2): a multicentre, open-label, single-arm, phase 2 study von Goss, Glenwood, Dr Prof, Tsai, Chun-Ming, Prof, Shepherd, Frances A, Prof, Bazhenova, Lyudmila, Prof, Lee, Jong Seok, MD, Chang, Gee-Chen, MD, Crino, Lucio, MD, Satouchi, Miyako, MD, Chu, Quincy, MD, Hida, Toyoaki, MD, Han, Ji-Youn, Prof, Juan, Oscar, MD, Dunphy, Frank, Prof, Nishio, Makoto, MD, Kang, Jin-Hyoung, MD, Majem, Margarita, MD, Mann, Helen, MSc, Cantarini, Mireille, MD, Ghiorghiu, Serban, MD, Mitsudomi, Tetsuya, Prof

Volltext

Comparison of pulmonary segmentectomy and lobectomy: Safety results of a randomized trial von Suzuki, Kenji, Saji, Hisashi, Aokage, Keiju, Watanabe, Shun-ichi, Okada, Morihito, Mizusawa, Junki, Nakajima, Ryu, Tsuboi, Masahiro, Nakamura, Shinichiro, Nakamura, Kenichi, Mitsudomi, Tetsuya, Asamura, Hisao

Volltext

Neoadjuvant Nivolumab plus Chemotherapy in Resectable Lung Cancer von Forde, Patrick M., Spicer, Jonathan, Lu, Shun, Provencio, Mariano, Mitsudomi, Tetsuya, Awad, Mark M., Felip, Enriqueta, Broderick, Stephen R., Brahmer, Julie R., Swanson, Scott J., Kerr, Keith, Wang, Changli, Ciuleanu, Tudor-Eliade, Saylors, Gene B., Tanaka, Fumihiro, Ito, Hiroyuki, Chen, Ke-Neng, Liberman, Moishe, Vokes, Everett E., Taube, Janis M., Dorange, Cecile, Cai, Junliang, Fiore, Joseph, Jarkowski, Anthony, Balli, David, Sausen, Mark, Pandya, Dimple, Calvet, Christophe Y., Girard, Nicolas

Volltext

A single-arm study of sublobar resection for ground-glass opacity dominant peripheral lung cancer von Suzuki, Kenji, Watanabe, Shun-ichi, Wakabayashi, Masashi, Saji, Hisashi, Aokage, Keiju, Moriya, Yasumitsu, Yoshino, Ichiro, Tsuboi, Masahiro, Nakamura, Shinichiro, Nakamura, Kenichi, Mitsudomi, Tetsuya, Asamura, Hisao

Volltext

Heterogeneous Distribution of EGFR Mutations Is Extremely Rare in Lung Adenocarcinoma von YATABE, Yasushi, MATSUO, Keitaro, MITSUDOMI, Tetsuya

Volltext

Radiographically determined noninvasive adenocarcinoma of the lung: Survival outcomes of Japan Clinical Oncology Group 0201 von Asamura, Hisao, MD, Hishida, Tomoyuki, MD, Suzuki, Kenji, MD, Koike, Teruaki, MD, Nakamura, Kenichi, MD, Kusumoto, Masahiko, MD, Nagai, Kanji, MD, Tada, Hirohito, MD, Mitsudomi, Tetsuya, MD, Tsuboi, Masahiro, MD, Shibata, Taro, MSc, Fukuda, Haruhiko, MD

Volltext

Impact and predictors of acute exacerbation of interstitial lung diseases after pulmonary resection for lung cancer von Sato, Toshihiko, MD, PhD, Teramukai, Satoshi, PhD, Kondo, Haruhiko, MD, PhD, Watanabe, Atsushi, MD, PhD, Ebina, Masahito, MD, PhD, Kishi, Kazuma, MD, PhD, Fujii, Yoshitaka, MD, PhD, Mitsudomi, Tetsuya, MD, PhD, Yoshimura, Masahiro, MD, PhD, Maniwa, Tomohiro, MD, Suzuki, Kenji, MD, PhD, Kataoka, Kazuhiko, MD, PhD, Sugiyama, Yukihiko, MD, PhD, Kondo, Takashi, MD, PhD, Date, Hiroshi, MD, PhD

Volltext

Alectinib versus crizotinib in patients with ALK -positive non-small-cell lung cancer (J-ALEX): an open-label, randomised phase 3 trial von Hida, Toyoaki, MD, Nokihara, Hiroshi, MD, Kondo, Masashi, MD, Kim, Young Hak, MD, Azuma, Koichi, MD, Seto, Takashi, MD, Takiguchi, Yuichi, Prof, Nishio, Makoto, MD, Yoshioka, Hiroshige, MD, Imamura, Fumio, MD, Hotta, Katsuyuki, Prof, Watanabe, Satoshi, MD, Goto, Koichi, MD, Satouchi, Miyako, MD, Kozuki, Toshiyuki, MD, Shukuya, Takehito, MD, Nakagawa, Kazuhiko, Prof, Mitsudomi, Tetsuya, Prof, Yamamoto, Nobuyuki, Prof, Asakawa, Takashi, PhD, Asabe, Ryoichi, MS, Tanaka, Tomohiro, MS, Tamura, Tomohide, Dr

Volltext

IASLC Multidisciplinary Recommendations for Pathologic Assessment of Lung Cancer Resection Specimens After Neoadjuvant Therapy von Travis, William D., Dacic, Sanja, Wistuba, Ignacio, Sholl, Lynette, Adusumilli, Prasad, Bubendorf, Lukas, Bunn, Paul, Cascone, Tina, Chaft, Jamie, Chen, Gang, Chou, Teh-Ying, Cooper, Wendy, Erasmus, Jeremy J., Ferreira, Carlos Gil, Goo, Jin-Mo, Heymach, John, Hirsch, Fred R., Horinouchi, Hidehito, Kerr, Keith, Kris, Mark, Jain, Deepali, Kim, Young T., Lopez-Rios, Fernando, Lu, Shun, Mitsudomi, Tetsuya, Moreira, Andre, Motoi, Noriko, Nicholson, Andrew G., Oliveira, Ricardo, Papotti, Mauro, Pastorino, Ugo, Paz-Ares, Luis, Pelosi, Giuseppe, Poleri, Claudia, Provencio, Mariano, Roden, Anja C., Scagliotti, Giorgio, Swisher, Stephen G., Thunnissen, Erik, Tsao, Ming S., Vansteenkiste, Johan, Weder, Walter, Yatabe, Yasushi

Volltext

Role of EGFR mutations in lung cancers: prognosis and tumor chemosensitivity von Suda, Kenichi, Mitsudomi, Tetsuya

Volltext

Clinical and pathologic features of lung cancer expressing programmed cell death ligand 1 (PD-L1) von Shimoji, Masaki, Shimizu, Shigeki, Sato, Katsuaki, Suda, Kenichi, Kobayashi, Yoshihisa, Tomizawa, Kenji, Takemoto, Toshiki, Mitsudomi, Tetsuya

Volltext

Sensitivity and Resistance of MET Exon 14 Mutations in Lung Cancer to Eight MET Tyrosine Kinase Inhibitors In Vitro von Fujino, Toshio, Kobayashi, Yoshihisa, Suda, Kenichi, Koga, Takamasa, Nishino, Masaya, Ohara, Shuta, Chiba, Masato, Shimoji, Masaki, Tomizawa, Kenji, Takemoto, Toshiki, Mitsudomi, Tetsuya

Volltext

Advances in Target Therapy for Lung Cancer von Mitsudomi, Tetsuya

Volltext

Emerging oncogenic fusions other than ALK, ROS1, RET, and NTRK in NSCLC and the role of fusions as resistance mechanisms to targeted therapy von Suda, Kenichi, Mitsudomi, Tetsuya

Volltext

Gefitinib or Erlotinib vs Chemotherapy for EGFR Mutation-Positive Lung Cancer: Individual Patient Data Meta-Analysis of Overall Survival von Lee, Chee Khoon, Davies, Lucy, Wu, Yi-Long, Mitsudomi, Tetsuya, Inoue, Akira, Rosell, Rafael, Zhou, Caicun, Nakagawa, Kazuhiko, Thongprasert, Sumitra, Fukuoka, Masahiro, Lord, Sally, Marschner, Ian, Tu, Yu-Kang, Gralla, Richard J, Gebski, Val, Mok, Tony, Yang, James Chih-Hsin

Volltext

Characterization of EGFR T790M, L792F, and C797S Mutations as Mechanisms of Acquired Resistance to Afatinib in Lung Cancer von Kobayashi, Yoshihisa, Azuma, Koichi, Nagai, Hiroki, Kim, Young Hak, Togashi, Yosuke, Sesumi, Yuichi, Chiba, Masato, Shimoji, Masaki, Sato, Katsuaki, Tomizawa, Kenji, Takemoto, Toshiki, Nishio, Kazuto, Mitsudomi, Tetsuya

Volltext